Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection

Huang, Szu-TingSzu-TingHuangYang, Jia-LingJia-LingYangLin, Chi-YingChi-YingLinHuang, Sung-HsiSung-HsiHuangJANN-TAY WANGYU-CHUNG CHUANGYEE-CHUN CHENSHAN-CHWEN CHANG2023-05-032023-05-032023-041201-9712https://scholars.lib.ntu.edu.tw/handle/123456789/630704We analyzed the risk factors affecting linezolid treatment outcome in vancomycin-resistant Enterococcus (VRE) bloodstream infection (BSI).enLinezolid; Mortality; Pharmacodynamic; Vancomycin-resistant enterococci[SDGs]SDG3Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infectionjournal article10.1016/j.ijid.2023.01.035367365762-s2.0-85148898246WOS:000954925800001https://api.elsevier.com/content/abstract/scopus_id/85148898246